MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6602-260-267$20.00
Mol Pharmacol 66:260-267, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gautam, D.
Right arrow Articles by Wess, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gautam, D.
Right arrow Articles by Wess, J.

Cholinergic Stimulation of Salivary Secretion Studied with M1 and M3 Muscarinic Receptor Single- and Double-Knockout Mice

Dinesh Gautam, Thomas S. Heard, Yinghong Cui, Georgina Miller, Lanh Bloodworth, and Jürgen Wess

Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland (D.G., T.H., Y.C., L.B., J.W.) and Veterinary Resources Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland (G.M.)

Identification of the specific muscarinic acetylcholine receptor (mAChR) subtypes mediating stimulation of salivary secretion is of considerable clinical interest. Recent pharmacological and molecular genetic studies have yielded somewhat confusing and partially contradictory results regarding the involvement of individual mAChRs in this activity. In the present study, we re-examined the roles of M1 and M3 mAChRs in muscarinic agonist-mediated stimulation of salivary secretion by using M1 and M3 receptor single-knockout (KO) mice and newly generated M1/M3 receptor double-KO mice. When applied at a low dose (1 mg/kg, s.c.), the muscarinic agonist pilocarpine showed significantly reduced secretory activity in both M1 and M3 receptor single-KO mice. However, when applied at higher doses, pilocarpine induced only modestly reduced (5 mg/kg, s.c.) or unchanged (15 mg/kg, s.c.) salivation responses, respectively, in M1 and M3 receptor single-KO mice, indicating that the presence of either M1 or M3 receptors is sufficient to mediate robust salivary output. Quantitative reverse transcriptase-polymerase chain reaction studies with salivary gland tissue showed that the inactivation of the M1 or M3 mAChR genes did not lead to significantly altered mRNA levels of the remaining mAChR subtypes. Strikingly, the sialagogue activity of pilocarpine was abolished in M1/M3 receptor double-KO mice. However, salivary glands from M1/M3 receptor double-KO mice remained responsive to stimulation by the {beta}-adrenergic receptor agonist, (S)-isoproterenol. Taken together these studies support the concept that a mixture of M1 and M3 receptors mediates cholinergic stimulation of salivary flow.


Received January 15, 2004; accepted May 20, 2004

Address correspondence to: Dr. Jürgen Wess, Molecular Signaling Section, Lab. of Bioorganic Chemistry, NIH-NIDDK, Bldg. 8A, Room B1A-05, 8 Center Drive MSC 0810, Bethesda, MD 20892-0810. E-mail: jwess{at}helix.nih.gov




This article has been cited by other articles:


Home page
J. Physiol.Home page
N. Origlia, N. Kuczewski, E. Aztiria, D. Gautam, J. Wess, and L. Domenici
Muscarinic acetylcholine receptor knockout mice show distinct synaptic plasticity impairments in the visual cortex
J. Physiol., December 15, 2006; 577(3): 829 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. B. Proctor
Muscarinic receptors and salivary secretion
J Appl Physiol, April 1, 2006; 100(4): 1103 - 1104.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. Tobin, A. T. Ryberg, S. Gentle, and A. V. Edwards
Distribution and function of muscarinic receptor subtypes in the ovine submandibular gland
J Appl Physiol, April 1, 2006; 100(4): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
J. H. Southerland, G. W. Taylor, and S. Offenbacher
Diabetes and Periodontal Infection: Making the Connection
Clin. Diabetes, October 1, 2005; 23(4): 171 - 178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Xie, C. Drachenberg, M. Yamada, J. Wess, and J.-P. Raufman
Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G521 - G529.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Kuczewski, E. Aztiria, D. Gautam, J. Wess, and L. Domenici
Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice
J. Physiol., August 1, 2005; 566(3): 907 - 919.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Gautam, S.-J. Han, T. S. Heard, Y. Cui, G. Miller, L. Bloodworth, and J. Wess
Cholinergic Stimulation of Amylase Secretion from Pancreatic Acinar Cells Studied with Muscarinic Acetylcholine Receptor Mutant Mice
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 995 - 1002.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics